Cyrus Therapeutics is a leading biotechnology company that is discovering and developing innovative medicines to conquer chronic or life-threatening diseases with high unmet needs. We are committed to making our mission—‘drugging the undruggable targets’—possible with small molecule drugs as well as new chemical modalities such as targeted protein degraders.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 5f, Kd70 Building, 4, Jeongui-Ro 8-Gil, Songpa-Gu, Seoul,05836,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cyrustx.com
- Keywords
- SK bioscience.
- HQ
- Seoul
Cyrus Therapeutics Questions
Cyrus Therapeutics's website is http://www.cyrustx.com
Cyrus Therapeutics's LinkedIn profile is https://kr.linkedin.com/company/cyrus-therapeutics
Cyrus Therapeutics has
16 employees.
View email and phone details for 16
employees at Cyrus Therapeutics.
Cyrus Therapeutics's industry is
Biotechnology Research
Cyrus Therapeutics's top competitors are
Seawith Inc.,
Celltrion Inc,
Samsung Biologics,
Kist(Korea Institute Of Science And Technology),
Beigene,
Sk Bioscience,
Hanmi Pharmaceuticals,
Cyrus Biotechnology,
Radahaim,
Lunit Cancer Screening.
Cyrus Therapeutics's categories are Biotechnology Research
Cyrus Therapeutics's founding year is 2019
